AlphaYouDP
Insider buying
David Parrot bought $40K of Scribe Therapeutics, Inc. (SCTX) stock
David Parrot, Chief Financial Officer of Scribe Therapeutics, Inc. (SCTX), bought 2,666 shares of SCTX stock worth $40K, per an SEC Form 4 filed Jul 28, 2026.
It was an open-market purchase.
The trade happened on Mar 13, 2026, 137 days before it was made public.
- Traded
- Mar 13, 2026
- Disclosed
- Jul 28, 2026
- Filing delay
- 137 days
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More SCTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.